Psychosocial impact of hidradenitis suppurativa: a practical guide for clinicians

References

• Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–561.
   PubMed Web of Science ®Google Scholar
• Matusiak L. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol. 2018;183(6):e171–e177.
   PubMed Web of Science ®Google Scholar
• Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90(1062):216–221.
   PubMed Web of Science ®Google Scholar
• Onderdijk AJ, van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473–478.
   PubMed Web of Science ®Google Scholar
• Mac Mahon J, Kirthi S, Byrne N, et al. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas. 2020;11:21–26.
   PubMed Web of Science ®Google Scholar
• Schneider-Burrus S, Jost A, Peters EMJ, et al. Association of hidradenitis suppurativa with body image. JAMA Dermatol. 2018;154(4):447–451.
   PubMed Web of Science ®Google Scholar
• Kirby JS, Miller JJ, Adams DR, et al. Health care utilization patterns and costs for patients with hidradenitis suppurativa. JAMA Dermatol. 2014;150(9):937–944.
   PubMed Web of Science ®Google Scholar
• Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venerol. 2010;90(3):264–268.
   PubMed Web of Science ®Google Scholar
• Alavi A, Anooshirvani N, Kim WB, et al. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2015;16(1):61–65.
   PubMed Web of Science ®Google Scholar
• Kontochristopoulous G, Kouris A, Tzanetakou V, et al. Quality of life and psychosocial implications in hidradenitis suppurativa. J Am Acad Dermatol. 2017;76(6):ab211.
   Web of Science ®Google Scholar
• Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422–434.
   PubMed Web of Science ®Google Scholar
• Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S19–S22.
   PubMed Web of Science ®Google Scholar
• Kirby J, Thorlacius L, Villumsen B, et al. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. Br J Dermatol. 2020;183(2):340–348.
   PubMed Web of Science ®Google Scholar
• Gerard AJ, Feldman SR, Strowd L. Quality of life of patients with pyoderma gangrenosum and hidradenitis suppurativa. J Cutan Med Surg. 2015;19(4):391–396.
   PubMed Web of Science ®Google Scholar
• Patel ZS, Hoffman LK, Buse DC, et al. Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]. Curr Pain Headache Rep. 2017;21(12):49.
   PubMed Web of Science ®Google Scholar
• Machado MO, Stergiopoulos V, Maes M, et al. Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(8):939–945.
   PubMed Web of Science ®Google Scholar
• Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91(3):328–332.
   PubMed Web of Science ®Google Scholar
• Vazquez BG, Alikhan A, Weaver AL, et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133(1):97–103.
   PubMed Web of Science ®Google Scholar
• Patel KR, Lee HH, Rastogi S, et al. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(3):737–744.
   PubMed Web of Science ®Google Scholar
• Jalenques I, Ciortianu L, Pereira B, et al. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(2):542–553.
   PubMed Web of Science ®Google Scholar
• Wright S, Strunk A, Garg A. New onset depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol. 2020;83(5):1360–1366.
   PubMed Web of Science ®Google Scholar
• Farzanfar D, Dowlati Y, French LE, et al. Inflammation: a contributor to depressive comorbidity in inflammatory skin disease. Skin Pharmacol Physiol. 2018;31(5):246–251.
   PubMed Web of Science ®Google Scholar
• Pavon Blanco A, Turner MA, Petrof G, et al. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa? Br J Dermatol. 2019;180(2):338–345.
   PubMed Web of Science ®Google Scholar
• Butt M, Cotton C, Kirby JS. Support group utilization and impact for patients with hidradenitis suppurativa. J Am Acad Dermatol. 2020;83(1):216–219.
   PubMed Web of Science ®Google Scholar
• Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90.
   PubMed Web of Science ®Google Scholar
• McDonald K, Shelley A, Jafferany M. The PHQ-2 in dermatology-standardized screening for depression and suicidal ideation. JAMA Dermatol. 2018;154(2):139–141.
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Dunn KM, Chaffee T, et al. Diagnostic and clinical utility of the GAD-2 for screening anxiety symptoms in individuals with multiple sclerosis. Arch Phys Med Rehabil. 2018;99(10):2045–2049.
   PubMed Web of Science ®Google Scholar
• Uebelacker LA, German NM, Gaudiano BA, et al. Patient health questionnaire depression scale as a suicide screening instrument in depressed primary care patients: a cross-sectional study. Prim Care Companion CNS Disord. 2011;13(1):PCC.10m01027.
   PubMedGoogle Scholar
• Chernyshov P, Zouboulis C, Tomas‐Aragones L, et al. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on quality of life and patient-oriented outcomes and acne, rosacea and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019;33(9):1633–1643.
   PubMed Web of Science ®Google Scholar
• Alexander CG, Casalino LP, Tseng C, et al. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004;19(8):856–860.
   PubMed Web of Science ®Google Scholar
• United States USDoHaHS, Centers for Medicare & Medicaid Services. The accountable health-related social needs screening tool; 2020, June 19. Available from: https://innovation.cms.gov/files/worksheets/ahcm-screeningtool.pdf.
   Google Scholar
• El-Den S, Chen TF, Gan Y-L, et al. The psychometric properties of depression screening tools in primary healthcare settings: a systematic review. J Affect Disord. 2018;225:503–522.
   PubMed Web of Science ®Google Scholar
• Reddy S, Strunk A, Garg A. Comparative overall comorbidity burden among patients with hidradenitis suppurativa. JAMA Dermatol. 2019;155(7):797–802.
   PubMed Web of Science ®Google Scholar
• Kirby JS, Butt M, Esmann S, et al. Association of resilience with depression and health-related quality of life for patients with hidradenitis suppurativa. JAMA Dermatol. 2017;153(12):1263–1269.
   PubMed Web of Science ®Google Scholar
• Scheffers M, Van Busschbach JT, Bosscher RJ, et al. Body image in patients with mental disorders: characteristics, associations with diagnosis and treatment outcome. Compr Psychiatry. 2017;74:53–60.
   PubMed Web of Science ®Google Scholar
• Cash TF, Pruzinsky T. Body image: a handbook of theory, research, and clinical practice. New York, NY: The Guilford Press; 2004.
   Google Scholar
• Cash TF, Phillips KA, Santos MT, et al. Measuring “negative body image”: validation of the Body Image Disturbance Questionnaire in a nonclinical population. Body Image. 2004;1(4):363–372.
   Google Scholar
• Cash TF, Fleming EC. The impact of body image experiences: development of the body image quality of life inventory. Int J Eat Disord. 2002;31(4):455–460.
   PubMed Web of Science ®Google Scholar
• Cash TF, Jakatdar TA, Williams EF. The Body Image Quality of Life Inventory: further validation with college men and women. Body Image. 2004;1(3):279–287.
   PubMedGoogle Scholar
• Koumaki D, Efthymiou O, Bozi E, et al. Perspectives on perceived stigma and self-stigma in patients with hidradenitis suppurativa. Clin Cosmet Investig Dermatol. 2019;12:785–790.
   PubMed Web of Science ®Google Scholar
• Tzellos T, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther. 2020;10(1):63–69.
   PubMed Web of Science ®Google Scholar
• Cuenca-Barrales C, Montero-Vílchez T, Szepietowski JC, et al. Sexual impairment in patients with hidradenitis suppurativa: a systematic review. J Eur Acad Dermatol Venereol. 2021;35(2):345–352.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. Clin Dermatol. 2013;31(1):72–79.
   PubMed Web of Science ®Google Scholar
• Tomas-Aragones L, Marron SE. Body image and body dysmorphic concerns. Acta Derm Venereol. 2016;96(217):47–50.
   PubMedGoogle Scholar
• Rosen JC, Saltzberg E, Srebnik D. Cognitive behavior therapy for negative body image. Behav Ther. 1989;20(3):393–404.
   Web of Science ®Google Scholar
• van den Brink F, Vollmann M, Sternheim LC, et al. Negative body attitudes and sexual dissatisfaction in men: the mediating role of body self-consciousness during physical intimacy. Arch Sex Behav. 2018;47(3):693–701.
   PubMed Web of Science ®Google Scholar
• Strachan MD, Cash TF. Self-help for a negative body image: a comparison of components of a cognitive-behavioral program. Behav Ther. 2002;33(2):235–251.
   Web of Science ®Google Scholar
• Kwon YJ, Kim J-H, Kim M. The effects of a self-compassion program on body satisfaction, body shame, self-esteem and subjective well-being among female university students with negative body image. Kor J Stress Res. 2018;26(4):296–304.
   Google Scholar
• Janse I, Deckers I, van der Maten A, et al. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. Br J Dermatol. 2017;176(4):1042–1047.
   PubMed Web of Science ®Google Scholar
• Kurek A, Peters EM, Chanwangpong A, et al. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol. 2012;67(3):422–428.
   PubMed Web of Science ®Google Scholar
• Andersen PL, Nielsen RM, Sigsgaard V, et al. Theut Riis P. Body image quality of life in patients with hidradenitis suppurativa compared with other dermatological disorders. Acta Dermatol-Venereol. 2020;100(6–7):1–6.
   Google Scholar
• Alavi A, Farzanfar D, Rogalska T, et al. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018;4(2):74–79.
   PubMedGoogle Scholar
• Sampogna F, Abeni D, Gieler U, et al. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Derm Venereol. 2017;97(4):478–482.
   PubMed Web of Science ®Google Scholar
• Slyper M, Strunk A, Garg A. Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population‐based retrospective analysis. Br J Dermatol. 2018;179(2):502–503.
   PubMed Web of Science ®Google Scholar
• Wood SC. Clinical manifestations and therapeutic management of vulvar cellulitis and abscess: methicillin-resistant Staphylococcus aureus, necrotizing fasciitis, Bartholin abscess, Crohn disease of the vulva, hidradenitis suppurativa. Clin Obstet Gynecol. 2015;58(3):503–511.
   PubMed Web of Science ®Google Scholar
• Hunter WG, Hesson A, Davis JK, et al. Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates. BMC Health Serv Res. 2016;16(1):108.
   PubMedGoogle Scholar
• Włodarek K, Głowaczewska A, Matusiak Ł, et al. Psychosocial burden of hidradenitis suppurativa patients' partners. J Eur Acad Dermatol Venereol. 2020;34(8):1822–1827.
   PubMed Web of Science ®Google Scholar
• Marvel J, Vlahiotis A, Sainski-Nguyen A, et al. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019;9(9):e030579.
   PubMed Web of Science ®Google Scholar
• Argyropoulou M, Kanni T, Kyprianou M, et al. Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort. Br J Dermatol. 2019;180(5):1161–1168.
   PubMed Web of Science ®Google Scholar
• Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62(4):706–707.
   PubMed Web of Science ®Google Scholar
• Kluger N, Ranta M, Serlachius M. The burden of hidradenitis suppurativa in a cohort of patients in Southern Finland: a pilot study. Skin Appendage Disord. 2017;3(1):20–27.
   PubMed Web of Science ®Google Scholar
• Tzellos T, Yang H, Mu F, et al. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol. 2019;181(1):147–154.
   PubMed Web of Science ®Google Scholar
• Theut Riis P, Thorlacius L, Knudsen List E, et al. A pilot study of unemployment in patients with hidradenitis suppurativa in Denmark. Br J Dermatol. 2017;176(4):1083–1085.
   PubMed Web of Science ®Google Scholar
• Soliman YS, Hoffman LK, Guzman AK, et al. African American patients with hidradenitis suppurativa have significant health care disparities: a retrospective study. J Cutan Med Surg. 2019;23(3):334–336.
   PubMed Web of Science ®Google Scholar
• Deckers IE, Janse IC, van der Zee HH, et al. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol. 2016;75(4):755–759.
   PubMed Web of Science ®Google Scholar
• Wertenteil S, Strunk A, Garg A. Association of low socioeconomic status with hidradenitis suppurativa in the United States. JAMA Dermatol. 2018;154(9):1086–1088.
   PubMed Web of Science ®Google Scholar
• American College of Physicians. Cost distress screening and conversation guide. High value care web site [published 2019; cited 2020 June 19]. Available from: https://www.acponline.org/system/files/documents/clinical_information/high_value_care/clinician_resources/cost-of-care/1-cost-distress-and-conversation-guide_.pdf.
   Google Scholar
• Shay JJ. “Okay, I'm here, but I'm not talking!" Psychotherapy with the reluctant male. Psychother Theory Res Pract Training. 1996;33(3):503–513.
   Web of Science ®Google Scholar
• Thompson A, Hunt C, Issakidis C. Why wait? Reasons for delay and prompts to seek help for mental health problems in an Australian clinical sample. Soc Psychiatry Psychiatr Epidemiol. 2004;39(10):810–817.
   PubMed Web of Science ®Google Scholar
• Sareen J, Jagdeo A, Cox BJ, et al. Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands. Psychiatr Serv. 2007;58(3):357–364.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Boiman E, Goodwin FK. Insight and outcome in bipolar, unipolar, and anxiety disorders. Compr Psychiatry. 2000;41(3):167–171.
   PubMed Web of Science ®Google Scholar